These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5630956)

  • 1. Potentiation of apomorphine effect (compulsive gnawing behaviour) in mice.
    Pedersen V
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:63. PubMed ID: 5630956
    [No Abstract]   [Full Text] [Related]  

  • 2. Central effects of anticholergic drugs measured by the apomorphine gnawing test in mice.
    Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):1-16. PubMed ID: 5467751
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of pheniramine and chlorpheniramine on apomorphine induced compulsive gnawing in mice.
    Dadkar NK; Dohadwalla AN; Bhattacharya BK
    Psychopharmacology (Berl); 1976 Jul; 48(1):7-10. PubMed ID: 823575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of apomorphine-induced gnawing in mice.
    Hedley LR; Wallach MB
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):47-56. PubMed ID: 6682986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of dopamine in central effects of cocaine as measured by apomorphine gnawing test in mice.
    Dadkar NK; Dohadwalla AN; Bhattacharya BK
    Psychopharmacology (Berl); 1977 Apr; 52(2):115-7. PubMed ID: 407594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats.
    Ernst AM; Smelik PG
    Experientia; 1966 Dec; 22(12):837-8. PubMed ID: 5973232
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological effects of apomorphine on mice as tests for differentiation of antidepressants, cholinolytics and neuroleptics].
    Shchelkunov EL
    Farmakol Toksikol; 1968; 31(5):559-63. PubMed ID: 4387720
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Biol Psychiatry; 1982 Aug; 17(8):937-46. PubMed ID: 6288127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thymoleptics on behavior associated with changes in brain dopamine. II. Modification and potentiation of apomorphine-induced stimulation of mice.
    Molander L; Randrup A
    Psychopharmacology (Berl); 1976 Sep; 49(2):139-44. PubMed ID: 825900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the difference in the behavioral effects of apomorphine in C57BL/6 and DBA/2 mice.
    Vetulani J; Sansone M; Oliverio A
    Pharmacol Biochem Behav; 1982 Nov; 17(5):967-71. PubMed ID: 6891071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.
    Christensen AV; Nielsen IM
    Psychopharmacology (Berl); 1979 Apr; 62(2):111-6. PubMed ID: 111273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modifications on the amphetamine-induced hyperthermia in rats.
    Morpurgo C; Theobald W
    Eur J Pharmacol; 1968 Feb; 2(4):287-94. PubMed ID: 5642032
    [No Abstract]   [Full Text] [Related]  

  • 18. Does a true qualitative difference exist in the mode of action of neuroleptics and thymanaleptics on catecholamine neuron systems.
    Moller Nielsen I
    Mod Probl Pharmacopsychiatry; 1970; 5():68-70. PubMed ID: 5527172
    [No Abstract]   [Full Text] [Related]  

  • 19. Apomorphine-induced locomotion and gnawing: evidence that the experimental design greatly influences gnawing while locomotion remains unchanged.
    Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1977 Nov; 46(2):147-51. PubMed ID: 563330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.